Convexity Labs

HPK

Convexity Analyst · HPK
Speculativemedium confidenceTactical · no named thesis
Generated Jun 21, 2026

ANALYST NOTE: HPK (HighPeak Energy, Inc.) Date: 2026-06-13 Current Price: $7.18

1. Structural Readiness

Conservative Entry: — (Awaiting confirmed breakout) Aggressive/Pre-Breakout Entry: — (Not actionable on setup alone) Breakout Level: — (Not yet established) Current Price: $7.18 Extension: — (Cannot calculate extension without a defined breakout level or entry point) ATR Context: 7.7% (Very High)

Structural Assessment:

2. Thesis Layer

Thesis Classification: Tactical / Setup-Led Secular Exposure: None Named

At this date, HPK does not carry a named secular thesis (e.g., "Energy Transition Leader" or "Global Supply Shortage"). The investment case is strictly TACTICAL, driven by the quality of the technical setup and the immediate business fundamentals. There is no macro narrative to weight the conviction; the judgment rests entirely on the structural readiness of the chart and the operational execution reported by management. The absence of a named thesis means the setup quality and business execution are the sole drivers of conviction.

3. Business Overview

Company Profile: HighPeak Energy, Inc. is an independent crude oil and natural gas exploration and production company. It operates primarily in the Permian Basin, specifically the Midland Basin in West Texas, with core acreage in Howard and Borden Counties, and secondary presence in Scurry and Mitchell Counties (Evidence E9, E19).

Business Model & Operations: The company focuses on horizontal development drilling targeting the Wolfcamp A, Lower Spraberry, and Middle Spraberry formations (Evidence E20). Its revenue model is driven by the sale of crude oil, NGLs, and natural gas.

Operational Highlights (as of Q1 2026):

  • Production Growth: Production averaged approximately 46,000 BOEs per day, exceeding the guidance midpoint by 7.5%. Oil production specifically rose 10% quarter-over-quarter (Evidence E4, E6).
  • Cost Efficiency: Lease operating expenses (LOE) per BOE were more than 17% below the guided range and 22% below Q4 2025 levels (Evidence E5).
  • Capital Execution: The company exited the quarter with 18 wells in progress and is on track to deploy roughly 60% of its 2026 capital in the first half of the year (Evidence E1, E3).
  • Pipeline: The company expects to exit 2026 with roughly 9 to 10 Drilled but Uncompleted (DUC) wells, providing a near-term production buffer into 2027 (Evidence E2).
  • Financials: Excluding working capital changes, the company generated over $21 million in free cash flow for the quarter, a significant turnaround from a negative $42 million in the prior quarter (Evidence E8). However, the company reported a net loss of $127.4 million for the period, largely impacted by a $157 million loss on derivative instruments (Evidence E12, E13).
  • Customer Concentration: Sales to the largest purchaser accounted for 86% of total revenues in Q1 2026, indicating high concentration risk (Evidence E10).

4. Archetype and Conviction

Archetype: Cyclical Recovery Rationale: The name fits the Cyclical Recovery archetype due to the sharp operational inflection in Q1 2026. The company has moved from negative free cash flow to positive ($21M), reduced operating costs significantly, and is executing a disciplined capital plan with a robust DUC inventory. The "Recovery" aspect is evidenced by the turnaround in FCF and the operational efficiency gains (LOE down 22% vs Q4).

Conviction Stack:

  • Thesis Strength: Low (No named secular thesis; purely tactical).
  • Evidence Quality: High. The earnings transcript and SEC filings provide granular data on production, costs, and capital deployment. The FCF turnaround is a strong fundamental signal.
  • Structural Quality: Moderate. The setup is "Forming," meaning the technical structure is present but unconfirmed. The "Very High" ATR (7.7%) suggests the stock is volatile, which can lead to false breakouts or deep pullbacks.
  • Rerating Potential: Dependent on the confirmation of the breakout and sustained operational execution. The high concentration of revenue with a single purchaser (86%) is a structural overhang that must be weighed against the operational improvements.

Valuation Context: While specific valuation multiples (P/NAV, EV/EBITDA) are not provided in the evidence, the shift from negative to positive FCF ($21M vs -$42M) suggests the market may be re-rating the company from a distressed/cash-burn profile to a cash-generative profile, provided oil prices remain supportive.

5. Invalidations, Strengths, and Gaps

What Would Invalidate the Case:

  • Fundamental: A failure to maintain the 46,000 BOE/day production rate or a reversal in the LOE trend (costs rising above guidance).
  • Counterparty Risk: Disruption in sales to the primary purchaser (86% concentration).

What Would Strengthen the Case:

  • Fundamental: Continued expansion of the DUC inventory and sustained positive free cash flow generation.
  • Operational: Successful execution of the 2026 capex plan with the single rig and frac crew.

Gaps in Evidence:

  • Hedge Book Details: While 40% exposure to spot prices is noted, the specific terms and maturity of the hedge book are not detailed, leaving the downside protection profile unclear.
  • Debt Maturity: The evidence mentions a Senior Credit Facility but does not detail maturity dates or covenants, which is critical for a company with a history of net losses.

PRIVATE ANALYST CALL

Judgment: Speculative Confidence: medium Key evidence: Q1 2026 FCF turnaround to positive $21M from negative $42M; Production beat guidance by 7.5% with 10% QoQ oil growth; LOE per BOE down 22% vs Q4 2025. Key risks: 86% revenue concentration with single purchaser; Net loss of $127M driven by $157M derivative losses; Very High ATR (7.7%) indicating elevated volatility risk; Setup is forming but not confirmed. Sizing hint: Position size should be reduced relative to confirmed breakouts due to the "forming" status and high volatility. Expected path: Management expects to deploy 60% of 2026 capex in H1 and exit with 9-10 DUCs; production growth should continue if execution holds. Expected horizon: 3 to 6 months for the forming coil to resolve into a breakout or invalidation.

Loading chart...
Exhibit 1: HPK daily candlestick — no active setup overlay.

Source-backed evidence anchors and catalysts land once Convexity finishes coverage for HPK.

Core assumptions for this name haven't been articulated yet — they land alongside the rerating thesis.

Value picture unavailable — no financial spine on file for HPK.

Layer B fundamentals snapshot not yet available. Highlights land once Convexity finishes the classification.

Coverage: